Global Primary Biliary Cirrhosis Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Primary Biliary Cirrhosis Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Primary Biliary Cirrhosis Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Primary Biliary Cirrhosis Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Primary Biliary Cirrhosis Drug Market Segmentations:

    By Players:

    • Johnson & Johnson

    • Enanta Pharmaceuticals, Inc

    • NGM Biopharmaceuticals, Inc

    • MediGene AG

    • Virobay Inc

    • AlbireoPharma

    • Dr Falk Pharma GmbH

    • GlaxoSmithKline Plc

    • Intercept Pharmaceuticals, Inc

    • CymaBay Therapeutics, Inc

    By Types:

    • Budesonide

    • FFP-104

    • GSK-2330672

    • MBX-8025

    • NGM-282

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Primary Biliary Cirrhosis Drug Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Budesonide from 2014 to 2026

      • 1.3.2 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of FFP-104 from 2014 to 2026

      • 1.3.3 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of GSK-2330672 from 2014 to 2026

      • 1.3.4 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of MBX-8025 from 2014 to 2026

      • 1.3.5 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of NGM-282 from 2014 to 2026

      • 1.3.6 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Clinic from 2014 to 2026

      • 1.4.2 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.3 Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Primary Biliary Cirrhosis Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Primary Biliary Cirrhosis Drug Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Primary Biliary Cirrhosis Drug by Major Types

      • 3.4.1 Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Budesonide

      • 3.4.2 Primary Biliary Cirrhosis Drug Market Size and Growth Rate of FFP-104

      • 3.4.3 Primary Biliary Cirrhosis Drug Market Size and Growth Rate of GSK-2330672

      • 3.4.4 Primary Biliary Cirrhosis Drug Market Size and Growth Rate of MBX-8025

      • 3.4.5 Primary Biliary Cirrhosis Drug Market Size and Growth Rate of NGM-282

      • 3.4.6 Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others

    4 Segmentation of Primary Biliary Cirrhosis Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Primary Biliary Cirrhosis Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Primary Biliary Cirrhosis Drug in Clinic

      • 4.4.2 Market Size and Growth Rate of Primary Biliary Cirrhosis Drug in Hospital

      • 4.4.3 Market Size and Growth Rate of Primary Biliary Cirrhosis Drug in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Primary Biliary Cirrhosis Drug Production Analysis by Major Regions

    • 5.2 Global Primary Biliary Cirrhosis Drug Consumption Analysis by Major Regions

    • 5.3 Global Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis

    6 Product Commodity of Primary Biliary Cirrhosis Drug Market in Major Countries

    • 6.1 Top 5 Export Countries in Primary Biliary Cirrhosis Drug market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Primary Biliary Cirrhosis Drug market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Primary Biliary Cirrhosis Drug market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Primary Biliary Cirrhosis Drug market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Primary Biliary Cirrhosis Drug market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Primary Biliary Cirrhosis Drug market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Primary Biliary Cirrhosis Drug Landscape Analysis

    • 7.1 North America Primary Biliary Cirrhosis Drug Landscape Analysis by Major Types

    • 7.2 North America Primary Biliary Cirrhosis Drug Landscape Analysis by Major End-Users

    • 7.3 North America Primary Biliary Cirrhosis Drug Landscape Analysis by Major Countries

      • 7.3.1 United States Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 7.3.2 Canada Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 7.3.3 Mexico Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

    8 Europe Primary Biliary Cirrhosis Drug Landscape Analysis

    • 8.1 Europe Primary Biliary Cirrhosis Drug Landscape Analysis by Major Types

    • 8.2 Europe Primary Biliary Cirrhosis Drug Landscape Analysis by Major End-Users

    • 8.3 Europe Primary Biliary Cirrhosis Drug Landscape Analysis by Major Countries

      • 8.3.1 Germany Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.2 UK Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.3 France Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.4 Italy Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.6 Spain Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.7 Belgium Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.8 Poland Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.9 Russia Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 8.3.10 Turkey Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

    9 Asia Pacific Primary Biliary Cirrhosis Drug Landscape Analysis

    • 9.1 Asia Pacific Primary Biliary Cirrhosis Drug Landscape Analysis by Major Types

    • 9.2 Asia Pacific Primary Biliary Cirrhosis Drug Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Primary Biliary Cirrhosis Drug Landscape Analysis by Major Countries

      • 9.3.1 China Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 9.3.2 Japan Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 9.3.4 India Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 9.3.6 South Korea Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 10.3.2 Brazil Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 10.3.3 Nigeria Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

      • 10.3.4 South Africa Primary Biliary Cirrhosis Drug Market Volume and Growth Rate 

      • 10.3.5 Argentina Primary Biliary Cirrhosis Drug Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Johnson & Johnson

      • 11.1.1 Johnson & Johnson Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Enanta Pharmaceuticals, Inc

      • 11.2.1 Enanta Pharmaceuticals, Inc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 NGM Biopharmaceuticals, Inc

      • 11.3.1 NGM Biopharmaceuticals, Inc Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 MediGene AG

      • 11.4.1 MediGene AG Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Virobay Inc

      • 11.5.1 Virobay Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 AlbireoPharma

      • 11.6.1 AlbireoPharma Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Dr Falk Pharma GmbH

      • 11.7.1 Dr Falk Pharma GmbH Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 GlaxoSmithKline Plc

      • 11.8.1 GlaxoSmithKline Plc Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Intercept Pharmaceuticals, Inc

      • 11.9.1 Intercept Pharmaceuticals, Inc Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 CymaBay Therapeutics, Inc

      • 11.10.1 CymaBay Therapeutics, Inc Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 103 Figures and 192 Tables)

    • Figure Product Picture

    • Figure Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Budesonide from 2014 to 2026

    • Figure Primary Biliary Cirrhosis Drug Market Size and Growth Rate of FFP-104 from 2014 to 2026

    • Figure Primary Biliary Cirrhosis Drug Market Size and Growth Rate of GSK-2330672 from 2014 to 2026

    • Figure Primary Biliary Cirrhosis Drug Market Size and Growth Rate of MBX-8025 from 2014 to 2026

    • Figure Primary Biliary Cirrhosis Drug Market Size and Growth Rate of NGM-282 from 2014 to 2026

    • Figure Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Global Primary Biliary Cirrhosis Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Primary Biliary Cirrhosis Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Primary Biliary Cirrhosis Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Primary Biliary Cirrhosis Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Primary Biliary Cirrhosis Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Primary Biliary Cirrhosis Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Budesonide

    • Figure Market Size and Growth Rate of FFP-104

    • Figure Market Size and Growth Rate of GSK-2330672

    • Figure Market Size and Growth Rate of MBX-8025

    • Figure Market Size and Growth Rate of NGM-282

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Primary Biliary Cirrhosis Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Primary Biliary Cirrhosis Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Others

    • Table Global Primary Biliary Cirrhosis Drug Production by Major Regions

    • Table Global Primary Biliary Cirrhosis Drug Production Share by Major Regions

    • Figure Global Primary Biliary Cirrhosis Drug Production Share by Major Regions in 2014

    • Figure Global Primary Biliary Cirrhosis Drug Production Share by Major Regions in 2018

    • Figure Global Primary Biliary Cirrhosis Drug Production Share by Major Regions in 2026

    • Table Global Primary Biliary Cirrhosis Drug Consumption by Major Regions

    • Table Global Primary Biliary Cirrhosis Drug Consumption Share by Major Regions

    • Figure Global Primary Biliary Cirrhosis Drug Consumption Share by Major Regions in 2014

    • Figure Global Primary Biliary Cirrhosis Drug Consumption Share by Major Regions in 2018

    • Figure Global Primary Biliary Cirrhosis Drug Consumption Share by Major Regions in 2026

    • Table North America Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis

    • Table Europe Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Primary Biliary Cirrhosis Drug market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Primary Biliary Cirrhosis Drug market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Primary Biliary Cirrhosis Drug market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Primary Biliary Cirrhosis Drug market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Primary Biliary Cirrhosis Drug Consumption by Types from 2014 to 2026

    • Table North America Primary Biliary Cirrhosis Drug Consumption Share by Types from 2014 to 2026

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by Types in 2014

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by Types in 2018

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by Types in 2026

    • Table North America Primary Biliary Cirrhosis Drug Consumption by End-Users from 2014 to 2026

    • Table North America Primary Biliary Cirrhosis Drug Consumption Share by End-Users from 2014 to 2026

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2014

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2018

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2026

    • Table North America Primary Biliary Cirrhosis Drug Consumption by Major Countries from 2014 to 2026

    • Table North America Primary Biliary Cirrhosis Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2014

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2018

    • Figure North America Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2026

    • Figure United States Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Primary Biliary Cirrhosis Drug Consumption by Types from 2014 to 2026

    • Table Europe Primary Biliary Cirrhosis Drug Consumption Share by Types from 2014 to 2026

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by Types in 2014

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by Types in 2018

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by Types in 2026

    • Table Europe Primary Biliary Cirrhosis Drug Consumption by End-Users from 2014 to 2026

    • Table Europe Primary Biliary Cirrhosis Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2014

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2018

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2026

    • Table Europe Primary Biliary Cirrhosis Drug Consumption by Major Countries from 2014 to 2026

    • Table Europe Primary Biliary Cirrhosis Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2014

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2018

    • Figure Europe Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2026

    • Figure Germany Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure France Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Primary Biliary Cirrhosis Drug Consumption by Types from 2014 to 2026

    • Table Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by Types in 2014

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by Types in 2018

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by Types in 2026

    • Table Asia Pacific Primary Biliary Cirrhosis Drug Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2014

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2018

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2026

    • Table Asia Pacific Primary Biliary Cirrhosis Drug Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2026

    • Figure China Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandPrimary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure India Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Primary Biliary Cirrhosis Drug Consumption Share by Major Countries in 2026

    • Figure GCC Countries Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Primary Biliary Cirrhosis Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Enanta Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enanta Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Enanta Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Enanta Pharmaceuticals, Inc

    • Table Product and Service Introduction of Enanta Pharmaceuticals, Inc

    • Table Company Profile and Development Status of NGM Biopharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NGM Biopharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of NGM Biopharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of NGM Biopharmaceuticals, Inc

    • Table Product and Service Introduction of NGM Biopharmaceuticals, Inc

    • Table Company Profile and Development Status of MediGene AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MediGene AG

    • Figure Sales and Growth Rate Analysis of MediGene AG

    • Figure Revenue and Market Share Analysis of MediGene AG

    • Table Product and Service Introduction of MediGene AG

    • Table Company Profile and Development Status of Virobay Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Virobay Inc

    • Figure Sales and Growth Rate Analysis of Virobay Inc

    • Figure Revenue and Market Share Analysis of Virobay Inc

    • Table Product and Service Introduction of Virobay Inc

    • Table Company Profile and Development Status of AlbireoPharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AlbireoPharma

    • Figure Sales and Growth Rate Analysis of AlbireoPharma

    • Figure Revenue and Market Share Analysis of AlbireoPharma

    • Table Product and Service Introduction of AlbireoPharma

    • Table Company Profile and Development Status of Dr Falk Pharma GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Falk Pharma GmbH

    • Figure Sales and Growth Rate Analysis of Dr Falk Pharma GmbH

    • Figure Revenue and Market Share Analysis of Dr Falk Pharma GmbH

    • Table Product and Service Introduction of Dr Falk Pharma GmbH

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Intercept Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intercept Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Intercept Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Intercept Pharmaceuticals, Inc

    • Table Product and Service Introduction of Intercept Pharmaceuticals, Inc

    • Table Company Profile and Development Status of CymaBay Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CymaBay Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of CymaBay Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of CymaBay Therapeutics, Inc

    • Table Product and Service Introduction of CymaBay Therapeutics, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.